Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 12, 2003, Pages 1959-1961

  Aslanian, Robert ^a   Mutahi, Mwangi Wa ^a   Shih, Neng Yang ^a   Piwinski, John J ^a   West, Robert ^a   Williams, Shirley M ^a   She, Susan ^a   Wu, Ren Long ^a   Hey, John A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC AMINE; CHLORPHENIRAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; LIGAND;

ARTICLE; CHEMICAL PARAMETERS; CHEMICAL PROCEDURES; DRUG IDENTIFICATION; DRUG RESEARCH; DRUG SYNTHESIS;

EID: 0037763942     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00357-3     Document Type: Article

References (17)

1. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. Pharmacol. Rev. 49:1997;253.
2. Leurs R., Blandina P., Tedford C., Timmerman H. Trends Pharmacol. Sci. 19:1998;177.
3. McLeod R.L., Mingo G.G., Herczku C., DeGennaro-Culver F., Kreutner W., Egan R.W., Hey J.A. Am. J. Rhinol. 13:1999;391.
4. (a) Billah M.M., Chapman R.W., Egan R.W., Gilchrest H., Piwinski J.J., Sherwood J., Siegel M.I., West R.E., Kreutner W. J. Pharmacol. Exp. Ther. 252:1990;1090
5. (b) Maynard G.D., Bratton L.D., Kane J.M., Burkholder T.P., Santiago B., Stewart K.T., Kudlacz E.M., Shatzer S.A., Knippenberg R.W., Farrell A.M., Logan D.E. Bioorg. Med. Chem. Lett. 7:1997;2819
6. (c) Schulze F.R., Buschauer A., Schunack W. Eur. J. Pharm. Sci. 6:1998;177
7. (d) Zhang M.Q., van de Stolpe A., Zuiderveld O.P., Timmerman H. Eur. J. Med. Chem. 32:1997;95.
8. (a) Hüls A., Purand K., Stark H., Ligneau X., Arrang J.-M., Schwartz J.-C., Schunack W. Bioorg. Med. Chem. Lett. 6:1996;2013
9. (b) Walczynski K., Guryn R., Zuiderveld O.P., Timmerman H. Il Farmaco. 54:1999;684.
10. Anthes J.A., Gilchrest H., Richard C., Eckel S., Hesk D., West R.E., Williams S.M., Greenfeder S., Billah M., Kreutner W., Egan R.W. Eur. J. Pharmacol. 449:2002;229.
11. Vollinga R.C., Menge W.M.P.B., Leurs R., Timmerman H. J. Med. Chem. 38:1995;266.
12. Basha A., Lipton M., Weinreb S.M. Tetrahedron Lett. 48:1997;4171.
13. Browne L.J., Gude C., Rodriguez H., Steele R.E. J. Med. Chem. 34:1991;725.
14. α-methyl histamine was used as the radioligand.
15. 3H]Pyrilamine was used as the radioligand.
16. Wieland K., Ter Laak A., Smit M.J., Kuhne R., Timmerman H., Leurs R. J. Biol. Chem. 274:1999;29994.
17. i determination.